581 related articles for article (PubMed ID: 25489086)
41. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
42. Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats.
Sticht MA; Lau DJ; Keenan CM; Cavin JB; Morena M; Vemuri VK; Makriyannis A; Cravatt BF; Sharkey KA; Hill MN
Br J Pharmacol; 2019 May; 176(10):1524-1540. PubMed ID: 30051485
[TBL] [Abstract][Full Text] [Related]
43. Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses.
Busquets-Garcia A; Puighermanal E; Pastor A; de la Torre R; Maldonado R; Ozaita A
Biol Psychiatry; 2011 Sep; 70(5):479-86. PubMed ID: 21684528
[TBL] [Abstract][Full Text] [Related]
44. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
45. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.
Bradshaw HB; Rimmerman N; Hu SS; Benton VM; Stuart JM; Masuda K; Cravatt BF; O'Dell DK; Walker JM
BMC Biochem; 2009 May; 10():14. PubMed ID: 19460156
[TBL] [Abstract][Full Text] [Related]
46. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway.
McLaughlin RJ; Hill MN; Bambico FR; Stuhr KL; Gobbi G; Hillard CJ; Gorzalka BB
Eur Neuropsychopharmacol; 2012 Sep; 22(9):664-71. PubMed ID: 22325231
[TBL] [Abstract][Full Text] [Related]
47. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.
Liu J; Cinar R; Xiong K; Godlewski G; Jourdan T; Lin Y; Ntambi JM; Kunos G
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18832-7. PubMed ID: 24191036
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure.
Rivera P; Fernández-Arjona MDM; Silva-Peña D; Blanco E; Vargas A; López-Ávalos MD; Grondona JM; Serrano A; Pavón FJ; Rodríguez de Fonseca F; Suárez J
Biochem Pharmacol; 2018 Nov; 157():244-257. PubMed ID: 30098312
[TBL] [Abstract][Full Text] [Related]
49. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
[TBL] [Abstract][Full Text] [Related]
51. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
Smaga I; Bystrowska B; Gawliński D; Pomierny B; Stankowicz P; Filip M
Neurotox Res; 2014 Aug; 26(2):190-206. PubMed ID: 24652522
[TBL] [Abstract][Full Text] [Related]
52. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
53. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.
Wu HF; Lu TY; Chu MC; Chen PS; Lee CW; Lin HC
Neuropharmacology; 2020 Jan; 162():107736. PubMed ID: 31398381
[TBL] [Abstract][Full Text] [Related]
54. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
[TBL] [Abstract][Full Text] [Related]
55. THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.
Aguilar DD; Giuffrida A; Lodge DJ
J Psychopharmacol; 2016 Feb; 30(2):169-81. PubMed ID: 26510449
[TBL] [Abstract][Full Text] [Related]
56. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
57. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
58. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
[TBL] [Abstract][Full Text] [Related]
59. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
Cross-Mellor SK; Ossenkopp KP; Piomelli D; Parker LA
Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
[TBL] [Abstract][Full Text] [Related]
60. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.
Hill MN; McLaughlin RJ; Morrish AC; Viau V; Floresco SB; Hillard CJ; Gorzalka BB
Neuropsychopharmacology; 2009 Dec; 34(13):2733-45. PubMed ID: 19710634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
